Michelle Kieszling, | |
4775 Whitman Ln Se, Lacey, WA 98513-2245 | |
(360) 438-6314 | |
Not Available |
Full Name | Michelle Kieszling |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 4775 Whitman Ln Se, Lacey, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184989352 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | PH00060138 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Michelle Kieszling, 4775 Whitman Ln Se, Lacey, WA 98513-2245 Ph: () - | Michelle Kieszling, 4775 Whitman Ln Se, Lacey, WA 98513-2245 Ph: (360) 438-6314 |
News Archive
As the debate about healthcare in the United States rages, four insightful articles in the March 2011 issue of The American Journal of Medicine strive to add reasoned arguments and empirical research findings to the dialog.
New research from Uppsala University shows promising progress in the use of stem cells for treatment of spinal cord injury. The results, which are published in the scientific journal Scientific Reports, show that human stem cells that are transplanted to the injured spinal cord contribute to restoration of some sensory functions.
Screening all emergency room patients for carbon monoxide poisoning is a simple yet potentially life-saving practice that can be done even in a high-volume urban hospital, according to new research by emergency physicians at Rhode Island Hospital.
Whether or not you are a smoker could condition how the coronavirus affects you. At least that is what numerous researchers are saying, insisting that tobacco use is to blame for the weakened cardiovascular systems which are at greatest risk from COVID-19.
Celldex Therapeutics, Inc. today announced that it has received a sublicense income payment of $3 million from TopoTarget A/S as a result of the recent co-development and commercialization agreement between TopoTarget and Spectrum Pharmaceuticals, Inc. for Belinostat, a novel histone deacetylase (HDAC) inhibitor for the treatment of cancer.
› Verified 8 days ago
Donna Quach, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8230 Martin Way E, Lacey, WA 98516 Phone: 360-456-0444 | |
Dr. Yen Vo Choum, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1243 Marvin Rd Ne, Lacey, WA 98516 Phone: 360-252-2235 | |
Lucas Walker, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5110 Yelm Hwy Se, Lacey, WA 98503 Phone: 360-252-2907 | |
Lauren Armijo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 665 Sleater Kinney Rd Se, Lacey, WA 98503 Phone: 360-486-8927 | |
Dr. Nicole Marie Miller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4700 Yelm Hwy Se, Lacey, WA 98503 Phone: 360-438-0081 Fax: 360-438-0082 | |
Dr. Michael Herman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1138 Golf Club Rd Se, Apt 102, Lacey, WA 98503 Phone: 619-922-0033 | |
Helen Leung, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8230 Martin Way E, Lacey, WA 98516 Phone: 360-456-0444 |